JP2011500697A5 - - Google Patents

Download PDF

Info

Publication number
JP2011500697A5
JP2011500697A5 JP2010530054A JP2010530054A JP2011500697A5 JP 2011500697 A5 JP2011500697 A5 JP 2011500697A5 JP 2010530054 A JP2010530054 A JP 2010530054A JP 2010530054 A JP2010530054 A JP 2010530054A JP 2011500697 A5 JP2011500697 A5 JP 2011500697A5
Authority
JP
Japan
Prior art keywords
methyl
phenyl
bipyrrolidinyl
amide
carboxylic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010530054A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011500697A (ja
JP5380455B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2008/079763 external-priority patent/WO2009052068A1/en
Publication of JP2011500697A publication Critical patent/JP2011500697A/ja
Publication of JP2011500697A5 publication Critical patent/JP2011500697A5/ja
Application granted granted Critical
Publication of JP5380455B2 publication Critical patent/JP5380455B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2010530054A 2007-10-17 2008-10-14 置換されたn−フェニル−ビピロリジン尿素及びその治療上の使用 Expired - Fee Related JP5380455B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US98060607P 2007-10-17 2007-10-17
US60/980,606 2007-10-17
PCT/US2008/079763 WO2009052068A1 (en) 2007-10-17 2008-10-14 Substituted n-phenyl-bipyrrolidine ureas and therapeutic use thereof

Publications (3)

Publication Number Publication Date
JP2011500697A JP2011500697A (ja) 2011-01-06
JP2011500697A5 true JP2011500697A5 (enExample) 2011-12-01
JP5380455B2 JP5380455B2 (ja) 2014-01-08

Family

ID=40248052

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010530054A Expired - Fee Related JP5380455B2 (ja) 2007-10-17 2008-10-14 置換されたn−フェニル−ビピロリジン尿素及びその治療上の使用

Country Status (24)

Country Link
US (1) US8222290B2 (enExample)
EP (1) EP2215058B1 (enExample)
JP (1) JP5380455B2 (enExample)
KR (1) KR20100082349A (enExample)
CN (1) CN101903341B (enExample)
AT (1) ATE534625T1 (enExample)
AU (1) AU2008312641A1 (enExample)
CA (1) CA2702933C (enExample)
CY (1) CY1112391T1 (enExample)
DK (1) DK2215058T3 (enExample)
ES (1) ES2378011T3 (enExample)
HR (1) HRP20120166T1 (enExample)
IL (1) IL205002A0 (enExample)
MA (1) MA31889B1 (enExample)
MX (1) MX2010003948A (enExample)
MY (1) MY148807A (enExample)
NZ (1) NZ584692A (enExample)
PL (1) PL2215058T3 (enExample)
PT (1) PT2215058E (enExample)
RS (1) RS52221B (enExample)
RU (1) RU2478094C2 (enExample)
SI (1) SI2215058T1 (enExample)
WO (1) WO2009052068A1 (enExample)
ZA (1) ZA201002114B (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2205558B1 (en) 2007-10-17 2012-07-25 Sanofi Substituted n-phenyl-pyrrolidinylmethylpyrrolidine amides and therapeutic use thereof as histamine h3 receptor modulators
ES2372332T3 (es) 2007-10-17 2012-01-18 Sanofi N-fenil-bipirrolidina carboxamidas sustituidas y su uso terapéutico.
SI2212282T1 (sl) * 2007-10-17 2012-01-31 Sanofi Sa Substituirani n-fenil-bipirolidin karboksamidi in njihova terapevtska uporaba
KR20090129927A (ko) 2008-06-13 2009-12-17 주식회사 엘지화학 발열체 및 이의 제조방법
CN101983181B (zh) 2008-06-13 2015-10-14 Lg化学株式会社 加热件及其制备方法
US10412788B2 (en) 2008-06-13 2019-09-10 Lg Chem, Ltd. Heating element and manufacturing method thereof
TW201206898A (en) * 2010-05-11 2012-02-16 Sanofi Aventis Substituted N-phenyl spirolactam bipyrrolidines, preparation and therapeutic use thereof
WO2011143148A1 (en) 2010-05-11 2011-11-17 Sanofi Substituted n-heteroaryl spirolactam bipyrrolidines, preparation and therapeutic use thereof
EP2569280B1 (en) 2010-05-11 2015-02-25 Sanofi Substituted phenyl cycloalkyl pyrrolidine (piperidine) spirolactams and amides, preparation and therapeutic use thereof
EP2569297A1 (en) 2010-05-11 2013-03-20 Sanofi Substituted n-heterocycloalkyl bipyrrolidinylphenyl amide derivatives, preparation and therapeutic use thereof
EP2569294B1 (en) * 2010-05-11 2015-03-11 Sanofi Substituted n-heteroaryl bipyrrolidine carboxamides, preparation and therapeutic use thereof
AR081498A1 (es) 2010-05-11 2012-09-19 Sanofi Aventis Derivados de n-alquil -y n-acil-tetrahidroisoquinolina sustituidos, preparacion y su uso terapeutico de los mismos
TW201206444A (en) 2010-05-11 2012-02-16 Sanofi Aventis Substituted N-heteroaryl tetrahydro-isoquinoline derivatives, preparation and therapeutic use thereof
AU2011329233A1 (en) 2010-11-15 2013-05-23 Abbvie Deutschland Gmbh & Co Kg NAMPT and ROCK inhibitors
US9079888B2 (en) * 2011-02-23 2015-07-14 Suven Life Sciences Limited Compounds as histamine H3 receptor ligands

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20020507A1 (es) * 2000-10-17 2002-06-25 Schering Corp Compuestos no-imidazoles como antagonistas del receptor histamina h3
EP1556046A1 (en) * 2002-10-23 2005-07-27 Janssen Pharmaceutica N.V. Phenylpiperidines and phenylpyrrolidines as histamine h3 receptor modulators
US7223788B2 (en) * 2003-02-14 2007-05-29 Sanofi-Aventis Deutschland Gmbh Substituted N-aryl heterocycles, process for their preparation and their use as medicaments
DE10306250A1 (de) * 2003-02-14 2004-09-09 Aventis Pharma Deutschland Gmbh Substituierte N-Arylheterozyklen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
BRPI0608523A2 (pt) 2005-03-17 2010-11-16 Lilly Co Eli composto ou um sal farmaceuticamente aceitável do mesmo, composição farmacêutica, métodos para inibir receptor de histamina h3 em um mamìfero, para tratar ou prevenir um distúrbio do sistema nervoso, para tratar ou prevenir obesidade e para tratar ou prevenir um distúrbio ou doença, e, uso de um composto ou um sal do mesmo
AU2006232871B9 (en) * 2005-04-01 2011-11-24 Eli Lilly And Company Histamine H3 receptor agents, preparation and therapeutic uses
MX2007016216A (es) * 2005-07-01 2008-03-11 Lilly Co Eli Agenes del receptor de histamina h3, preparacion y usos terapeuticos.
CA2627234A1 (en) * 2005-10-27 2007-05-03 Ucb Pharma, S.A. Compounds comprising a lactam or a lactam derivative moiety, processes for making them, and their uses
SI2212282T1 (sl) 2007-10-17 2012-01-31 Sanofi Sa Substituirani n-fenil-bipirolidin karboksamidi in njihova terapevtska uporaba
ES2372332T3 (es) 2007-10-17 2012-01-18 Sanofi N-fenil-bipirrolidina carboxamidas sustituidas y su uso terapéutico.
EP2205558B1 (en) 2007-10-17 2012-07-25 Sanofi Substituted n-phenyl-pyrrolidinylmethylpyrrolidine amides and therapeutic use thereof as histamine h3 receptor modulators

Similar Documents

Publication Publication Date Title
JP2011500697A5 (enExample)
CA2702933A1 (en) Substituted n-phenyl-bipyrrolidine ureas and therapeutic use thereof
JP2011500694A5 (enExample)
JP2009541461A5 (enExample)
JP2008110984A5 (enExample)
JP2011524906A5 (enExample)
JP2005526723A5 (enExample)
JP2011500693A5 (enExample)
RU2010119560A (ru) Замещенные n-фенилбипирролидинкарбоксамиды и их терапевтическое применение
NO341591B1 (no) 3-Z-[1-(4-(N-((4-metyl-piperazin-1-yl)-metylkarbonyl)-N-metyl-amino)-anilino)-1-fenyl-metylen]-6-metoksykarbonyl-2-indolinon, tautomerene, diastereomerene, enantiomerene, blandinger derav og saltene derav, og i kombinasjon med en ytterligere farmakologisk aktiv substans, for anvendelse i forebygging eller behandling av fibrose ved revmatoid artritt
RU2012129737A (ru) Замещенные бензамидные производные
JP2017510555A5 (enExample)
NZ600716A (en) Substituted isoquinolinones and quinazolinones
NO343929B3 (no) 1-[2-(2,4-dimetylfenylsulfanyl-fenyl]-piperazin som en forbindelse med kombinert serotoninreopptak, 5-HT3- og 5HT1A-aktivitet for behandlingen av kognitiv smerte
NZ603724A (en) Piperidine derivatives and their use for the treatment of metabolic disorders
JP2007508360A5 (enExample)
CA2587800A1 (en) Fused aminopiperidines as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
RU2010119528A (ru) Замещенные n-фенилбипирролидинкарбоксамиды и их применение в лечебных целях
JP2009527462A5 (enExample)
NZ617334A (en) Cyclopropyl amine derivatives
JP2010500345A5 (enExample)
JP2009537542A5 (enExample)
NZ598083A (en) New compositions of 1-[2-(2,4-dimethyl-phenylsulfanyl)-phenyl]piperazine
MX2010001080A (es) Pirrolidin-aril-eteres como antagonistas de receptor de nk3.
RU2008120850A (ru) Соединения и композиции в качестве ингибиторов протеинкиназ